Academic Journal
Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles.
| Τίτλος: | Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles. |
|---|---|
| Συγγραφείς: | Zhang L; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Han Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Lv D; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Yao P; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Chen L; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Yuan Y; Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China., Zhao J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Guo W; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Guo Z; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Ou Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. |
| Πηγή: | Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2026 Aug; Vol. 80 (8), pp. 655-664. Date of Electronic Publication: 2026 May 07. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1819 (Electronic) Linking ISSN: 13231316 NLM ISO Abbreviation: Psychiatry Clin Neurosci Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Carlton, Vic., Australia : Blackwell Science |
| Ιατρικοί όροι (MeSH): | Depressive Disorder, Treatment-Resistant*/therapy , Depressive Disorder, Treatment-Resistant*/diagnostic imaging , Depressive Disorder, Treatment-Resistant*/physiopathology , Depressive Disorder, Treatment-Resistant*/genetics , Cerebellum*/diagnostic imaging , Cerebellum*/physiopathology , Nerve Net*/physiopathology , Nerve Net*/diagnostic imaging , Cerebral Cortex*/diagnostic imaging , Cerebral Cortex*/physiopathology , Default Mode Network*/diagnostic imaging , Default Mode Network*/physiopathology , Electroconvulsive Therapy* , Connectome* , Transcriptome*, Humans ; Female ; Male ; Adult ; Middle Aged ; Magnetic Resonance Imaging |
| Περίληψη: | Aims: Electroconvulsive therapy (ECT) is an effective intervention for treatment-resistant depression (TRD). Although prior studies have identified cerebellar functional alterations following ECT, cerebellar-cerebral functional connectivity (FC) changes remain insufficiently explored. Methods: Cerebellar seeds were defined based on prior connectivity studies, targeting cerebellar regions functionally coupled with executive, default-mode, and affective-limbic networks. Seed-based cerebellar-cerebral FC analyses were conducted using neuroimaging data from 72 patients with TRD (52 of whom completed post-ECT assessment) and 63 healthy controls (HCs). Correlation analyses assessed clinical associations, and support vector regression was applied to predict treatment response using baseline FC. Neuroimaging-transcriptomic association analyses were conducted to identify gene expression patterns correlated with post-ECT FC alterations. Results: Compared to HCs, patients with TRD exhibited decreased cerebellar connectivity with the sensorimotor network (SMN) and the default-mode network (DMN). Following ECT, TRD patients showed significant alleviation of depressive symptoms, which was accompanied by a marked increase in cerebellar-DMN connectivity. Enhanced FCs between the left Crus II Conclusions: TRD is associated with reduced cerebellar-SMN and cerebellar-DMN connectivity. ECT may enhance cerebellar-DMN connectivity, potentially contributing to antidepressant effects. (© 2026 The Author(s). Psychiatry and Clinical Neurosciences © 2026 Japanese Society of Psychiatry and Neurology.) |
| References: | Front Neurosci. 2020 Jul 08;14:545. (PMID: 32742251) Psychiatry Res. 2020 Dec;294:113461. (PMID: 33038791) Psychoneuroendocrinology. 2025 Jul;177:107472. (PMID: 40288014) Neurosci Biobehav Rev. 2022 Jan;132:433-448. (PMID: 34890601) Am J Psychiatry. 2011 Jun;168(6):642-8. (PMID: 21362744) Neurosci Lett. 2011 Apr 15;493(3):122-6. (PMID: 21335060) Hum Brain Mapp. 2019 Feb 1;40(2):465-473. (PMID: 30240504) CNS Drugs. 2009 Aug;23(8):627-47. (PMID: 19594193) Brain Imaging Behav. 2020 Jun;14(3):753-761. (PMID: 30610527) PLoS One. 2012;7(9):e45263. (PMID: 23028892) J Affect Disord. 2025 Jun 15;379:615-623. (PMID: 40044090) Sci Bull (Beijing). 2019 Jul 30;64(14):953-954. (PMID: 36659803) Psychol Med. 2019 Jun;49(8):1357-1364. (PMID: 30229715) J ECT. 2002 Mar;18(1):58-9. (PMID: 11925524) Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:31-35. (PMID: 27665684) Psychiatry Res. 2024 Apr;334:115817. (PMID: 38430816) J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):367-78. (PMID: 15377747) Nat Neurosci. 2009 May;12(5):547-8. (PMID: 19363489) Cerebellum. 2012 Jun;11(2):352-65. (PMID: 21373864) J Affect Disord. 2019 Jan 1;242:195-210. (PMID: 30195173) Transl Psychiatry. 2025 Mar 17;15(1):86. (PMID: 40097427) Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:168-84. (PMID: 23268191) Brain. 2009 Apr;132(Pt 4):999-1012. (PMID: 19339252) Prev Sci. 2011 Dec;12(4):361-71. (PMID: 21732121) Front Psychiatry. 2015 Mar 02;6:28. (PMID: 25784881) Cerebellum. 2007;6(3):254-67. (PMID: 17786822) J Affect Disord. 2025 Apr 01;374:495-502. (PMID: 39824319) Can J Psychiatry. 2019 Jun;64(6):380-387. (PMID: 30763119) Brain Stimul. 2017 May - Jun;10(3):637-644. (PMID: 28162976) Commun Biol. 2019 Oct 10;2:370. (PMID: 31633061) Signal Transduct Target Ther. 2023 Aug 30;8(1):309. (PMID: 37644009) Transl Psychiatry. 2025 Apr 02;15(1):117. (PMID: 40175334) Psychophysiology. 1979 Nov;16(6):495-512. (PMID: 515293) Nature. 2012 Sep 20;489(7416):391-399. (PMID: 22996553) Hum Brain Mapp. 2018 Mar;39(3):1403-1411. (PMID: 29266749) MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):644-650. (PMID: 37318995) Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110621. (PMID: 36031163) J Affect Disord. 2019 Feb 1;244:92-99. (PMID: 30326347) Ann N Y Acad Sci. 2014 May;1316:29-52. (PMID: 24502540) J ECT. 2012 Dec;28(4):234-41. (PMID: 22820953) Sci Rep. 2019 Mar 25;9(1):5071. (PMID: 30911075) Hum Psychopharmacol. 2016 May;31(3):247-51. (PMID: 27062668) Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12562-12567. (PMID: 27791098) J Affect Disord. 2020 Oct 1;275:319-328. (PMID: 32734925) Neuroscience. 2015 Jul 9;298:329-35. (PMID: 25907440) Transl Psychiatry. 2018 Mar 6;8(1):57. (PMID: 29507282) World J Psychiatry. 2022 May 19;12(5):708-721. (PMID: 35663299) Epilepsia. 2015 Mar;56(3):382-92. (PMID: 25631544) PLoS One. 2011;6(5):e20035. (PMID: 21637831) J Neurol Sci. 2022 Mar 15;434:120095. (PMID: 34979372) Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:51-7. (PMID: 23352887) J ECT. 2016 Mar;32(1):49-54. (PMID: 26252558) Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110178. (PMID: 33197507) PLoS One. 2012;7(6):e39516. (PMID: 22724025) Psychiatry Res. 2023 Jun;324:115192. (PMID: 37054552) J Psychiatr Res. 2016 Nov;82:30-9. (PMID: 27459030) Am J Psychiatry. 2006 Nov;163(11):1905-17. (PMID: 17074942) Eur Neuropsychopharmacol. 2019 Aug;29(8):925-935. (PMID: 31279591) Mol Psychiatry. 2015 May;20(5):609-14. (PMID: 25092248) J Pain. 2010 Mar;11(3):287-90. (PMID: 19944649) CNS Neurosci Ther. 2024 Mar;30(3):e14690. (PMID: 38529527) Int J Psychophysiol. 2009 Apr;72(1):46-50. (PMID: 18824045) J Neurosci. 2009 Jul 1;29(26):8586-94. (PMID: 19571149) Cereb Cortex. 2009 Oct;19(10):2485-97. (PMID: 19592571) |
| Grant Information: | 82171508 National Natural Science Foundation of China; 2025JJ60706 Natural Science Foundation of Hunan Province |
| Contributed Indexing: | Keywords: cerebellum; functional connectivity; neuroimaging–transcription association analysis; the default‐mode network; treatment‐resistant depression |
| Entry Date(s): | Date Created: 20260508 Date Completed: 20260806 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13447124 |
| DOI: | 10.1111/pcn.70071 |
| PMID: | 42099010 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=14401819&ISBN=&volume=80&issue=8&date=20260801&spage=655&pages=655-664&title=Psychiatry and clinical neurosciences&atitle=Effects%20of%20electroconvulsive%20therapy%20on%20cerebellar-cerebral%20functional%20connectivity%20in%20patients%20with%20treatment-resistant%20depression%20and%20their%20correlations%20with%20gene%20expression%20profiles.&aulast=Zhang%20L&id=DOI:10.1111/pcn.70071 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42099010 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Han+Y%22">Han Y</searchLink>; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Lv+D%22">Lv D</searchLink>; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China.<br /><searchLink fieldCode="AU" term="%22Yao+P%22">Yao P</searchLink>; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Guo+W%22">Guo W</searchLink>; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.<br /><searchLink fieldCode="AU" term="%22Guo+Z%22">Guo Z</searchLink>; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China.<br /><searchLink fieldCode="AU" term="%22Ou+Y%22">Ou Y</searchLink>; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229513551%22">Psychiatry and clinical neurosciences</searchLink> [Psychiatry Clin Neurosci] 2026 Aug; Vol. 80 (8), pp. 655-664. <i>Date of Electronic Publication: </i>2026 May 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>9513551 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1440-1819 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213231316%22">13231316 </searchLink><i>NLM ISO Abbreviation: </i>Psychiatry Clin Neurosci <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Carlton, Vic., Australia : Blackwell Science – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant%22">Depressive Disorder, Treatment-Resistant*</searchLink>/<searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant+therapy%22">therapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant%22">Depressive Disorder, Treatment-Resistant*</searchLink>/<searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant+diagnostic+imaging%22">diagnostic imaging</searchLink> <br /><searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant%22">Depressive Disorder, Treatment-Resistant*</searchLink>/<searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant%22">Depressive Disorder, Treatment-Resistant*</searchLink>/<searchLink fieldCode="MM" term="%22Depressive+Disorder%2C+Treatment-Resistant+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Cerebellum%22">Cerebellum*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebellum+diagnostic+imaging%22">diagnostic imaging</searchLink> <br /><searchLink fieldCode="MM" term="%22Cerebellum%22">Cerebellum*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebellum+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Nerve+Net%22">Nerve Net*</searchLink>/<searchLink fieldCode="MM" term="%22Nerve+Net+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Nerve+Net%22">Nerve Net*</searchLink>/<searchLink fieldCode="MM" term="%22Nerve+Net+diagnostic+imaging%22">diagnostic imaging</searchLink> <br /><searchLink fieldCode="MM" term="%22Cerebral+Cortex%22">Cerebral Cortex*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebral+Cortex+diagnostic+imaging%22">diagnostic imaging</searchLink> <br /><searchLink fieldCode="MM" term="%22Cerebral+Cortex%22">Cerebral Cortex*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebral+Cortex+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Default+Mode+Network%22">Default Mode Network*</searchLink>/<searchLink fieldCode="MM" term="%22Default+Mode+Network+diagnostic+imaging%22">diagnostic imaging</searchLink> <br /><searchLink fieldCode="MM" term="%22Default+Mode+Network%22">Default Mode Network*</searchLink>/<searchLink fieldCode="MM" term="%22Default+Mode+Network+physiopathology%22">physiopathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Electroconvulsive+Therapy%22">Electroconvulsive Therapy*</searchLink> <br /><searchLink fieldCode="MM" term="%22Connectome%22">Connectome*</searchLink> <br /><searchLink fieldCode="MM" term="%22Transcriptome%22">Transcriptome*</searchLink><br /><searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Magnetic+Resonance+Imaging%22">Magnetic Resonance Imaging</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Aims: Electroconvulsive therapy (ECT) is an effective intervention for treatment-resistant depression (TRD). Although prior studies have identified cerebellar functional alterations following ECT, cerebellar-cerebral functional connectivity (FC) changes remain insufficiently explored.<br />Methods: Cerebellar seeds were defined based on prior connectivity studies, targeting cerebellar regions functionally coupled with executive, default-mode, and affective-limbic networks. Seed-based cerebellar-cerebral FC analyses were conducted using neuroimaging data from 72 patients with TRD (52 of whom completed post-ECT assessment) and 63 healthy controls (HCs). Correlation analyses assessed clinical associations, and support vector regression was applied to predict treatment response using baseline FC. Neuroimaging-transcriptomic association analyses were conducted to identify gene expression patterns correlated with post-ECT FC alterations.<br />Results: Compared to HCs, patients with TRD exhibited decreased cerebellar connectivity with the sensorimotor network (SMN) and the default-mode network (DMN). Following ECT, TRD patients showed significant alleviation of depressive symptoms, which was accompanied by a marked increase in cerebellar-DMN connectivity. Enhanced FCs between the left Crus II<subscript>Exec2</subscript> and the bilateral medial superior frontal gyrus were positively correlated with Hamilton Depression Rating Scale (HAMD) score reduction (r = 0.343, P = 0.026). Additionally, baseline FC of the left Crus II<subscript>Exec2</subscript> significantly predicted HAMD reduction (r = 0.412, P &lt; 0.001). Neuroimaging-transcription association analysis revealed these FC alterations were associated with normative gene patterns enriched in synaptic signaling, ion channel, and chromatin remodeling.<br />Conclusions: TRD is associated with reduced cerebellar-SMN and cerebellar-DMN connectivity. ECT may enhance cerebellar-DMN connectivity, potentially contributing to antidepressant effects.<br /> (© 2026 The Author(s). Psychiatry and Clinical Neurosciences © 2026 Japanese Society of Psychiatry and Neurology.) – Name: Ref Label: References Group: RefInfo Data: Front Neurosci. 2020 Jul 08;14:545. (PMID: <searchLink fieldCode="PM" term="%2232742251%22">32742251)</searchLink><br />Psychiatry Res. 2020 Dec;294:113461. (PMID: <searchLink fieldCode="PM" term="%2233038791%22">33038791)</searchLink><br />Psychoneuroendocrinology. 2025 Jul;177:107472. (PMID: <searchLink fieldCode="PM" term="%2240288014%22">40288014)</searchLink><br />Neurosci Biobehav Rev. 2022 Jan;132:433-448. (PMID: <searchLink fieldCode="PM" term="%2234890601%22">34890601)</searchLink><br />Am J Psychiatry. 2011 Jun;168(6):642-8. (PMID: <searchLink fieldCode="PM" term="%2221362744%22">21362744)</searchLink><br />Neurosci Lett. 2011 Apr 15;493(3):122-6. (PMID: <searchLink fieldCode="PM" term="%2221335060%22">21335060)</searchLink><br />Hum Brain Mapp. 2019 Feb 1;40(2):465-473. (PMID: <searchLink fieldCode="PM" term="%2230240504%22">30240504)</searchLink><br />CNS Drugs. 2009 Aug;23(8):627-47. (PMID: <searchLink fieldCode="PM" term="%2219594193%22">19594193)</searchLink><br />Brain Imaging Behav. 2020 Jun;14(3):753-761. (PMID: <searchLink fieldCode="PM" term="%2230610527%22">30610527)</searchLink><br />PLoS One. 2012;7(9):e45263. (PMID: <searchLink fieldCode="PM" term="%2223028892%22">23028892)</searchLink><br />J Affect Disord. 2025 Jun 15;379:615-623. (PMID: <searchLink fieldCode="PM" term="%2240044090%22">40044090)</searchLink><br />Sci Bull (Beijing). 2019 Jul 30;64(14):953-954. (PMID: <searchLink fieldCode="PM" term="%2236659803%22">36659803)</searchLink><br />Psychol Med. 2019 Jun;49(8):1357-1364. (PMID: <searchLink fieldCode="PM" term="%2230229715%22">30229715)</searchLink><br />J ECT. 2002 Mar;18(1):58-9. (PMID: <searchLink fieldCode="PM" term="%2211925524%22">11925524)</searchLink><br />Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:31-35. (PMID: <searchLink fieldCode="PM" term="%2227665684%22">27665684)</searchLink><br />Psychiatry Res. 2024 Apr;334:115817. (PMID: <searchLink fieldCode="PM" term="%2238430816%22">38430816)</searchLink><br />J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):367-78. (PMID: <searchLink fieldCode="PM" term="%2215377747%22">15377747)</searchLink><br />Nat Neurosci. 2009 May;12(5):547-8. (PMID: <searchLink fieldCode="PM" term="%2219363489%22">19363489)</searchLink><br />Cerebellum. 2012 Jun;11(2):352-65. (PMID: <searchLink fieldCode="PM" term="%2221373864%22">21373864)</searchLink><br />J Affect Disord. 2019 Jan 1;242:195-210. (PMID: <searchLink fieldCode="PM" term="%2230195173%22">30195173)</searchLink><br />Transl Psychiatry. 2025 Mar 17;15(1):86. (PMID: <searchLink fieldCode="PM" term="%2240097427%22">40097427)</searchLink><br />Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:168-84. (PMID: <searchLink fieldCode="PM" term="%2223268191%22">23268191)</searchLink><br />Brain. 2009 Apr;132(Pt 4):999-1012. (PMID: <searchLink fieldCode="PM" term="%2219339252%22">19339252)</searchLink><br />Prev Sci. 2011 Dec;12(4):361-71. (PMID: <searchLink fieldCode="PM" term="%2221732121%22">21732121)</searchLink><br />Front Psychiatry. 2015 Mar 02;6:28. (PMID: <searchLink fieldCode="PM" term="%2225784881%22">25784881)</searchLink><br />Cerebellum. 2007;6(3):254-67. (PMID: <searchLink fieldCode="PM" term="%2217786822%22">17786822)</searchLink><br />J Affect Disord. 2025 Apr 01;374:495-502. (PMID: <searchLink fieldCode="PM" term="%2239824319%22">39824319)</searchLink><br />Can J Psychiatry. 2019 Jun;64(6):380-387. (PMID: <searchLink fieldCode="PM" term="%2230763119%22">30763119)</searchLink><br />Brain Stimul. 2017 May - Jun;10(3):637-644. (PMID: <searchLink fieldCode="PM" term="%2228162976%22">28162976)</searchLink><br />Commun Biol. 2019 Oct 10;2:370. (PMID: <searchLink fieldCode="PM" term="%2231633061%22">31633061)</searchLink><br />Signal Transduct Target Ther. 2023 Aug 30;8(1):309. (PMID: <searchLink fieldCode="PM" term="%2237644009%22">37644009)</searchLink><br />Transl Psychiatry. 2025 Apr 02;15(1):117. (PMID: <searchLink fieldCode="PM" term="%2240175334%22">40175334)</searchLink><br />Psychophysiology. 1979 Nov;16(6):495-512. (PMID: <searchLink fieldCode="PM" term="%22515293%22">515293)</searchLink><br />Nature. 2012 Sep 20;489(7416):391-399. (PMID: <searchLink fieldCode="PM" term="%2222996553%22">22996553)</searchLink><br />Hum Brain Mapp. 2018 Mar;39(3):1403-1411. (PMID: <searchLink fieldCode="PM" term="%2229266749%22">29266749)</searchLink><br />MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):644-650. (PMID: <searchLink fieldCode="PM" term="%2237318995%22">37318995)</searchLink><br />Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110621. (PMID: <searchLink fieldCode="PM" term="%2236031163%22">36031163)</searchLink><br />J Affect Disord. 2019 Feb 1;244:92-99. (PMID: <searchLink fieldCode="PM" term="%2230326347%22">30326347)</searchLink><br />Ann N Y Acad Sci. 2014 May;1316:29-52. (PMID: <searchLink fieldCode="PM" term="%2224502540%22">24502540)</searchLink><br />J ECT. 2012 Dec;28(4):234-41. (PMID: <searchLink fieldCode="PM" term="%2222820953%22">22820953)</searchLink><br />Sci Rep. 2019 Mar 25;9(1):5071. (PMID: <searchLink fieldCode="PM" term="%2230911075%22">30911075)</searchLink><br />Hum Psychopharmacol. 2016 May;31(3):247-51. (PMID: <searchLink fieldCode="PM" term="%2227062668%22">27062668)</searchLink><br />Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12562-12567. (PMID: <searchLink fieldCode="PM" term="%2227791098%22">27791098)</searchLink><br />J Affect Disord. 2020 Oct 1;275:319-328. (PMID: <searchLink fieldCode="PM" term="%2232734925%22">32734925)</searchLink><br />Neuroscience. 2015 Jul 9;298:329-35. (PMID: <searchLink fieldCode="PM" term="%2225907440%22">25907440)</searchLink><br />Transl Psychiatry. 2018 Mar 6;8(1):57. (PMID: <searchLink fieldCode="PM" term="%2229507282%22">29507282)</searchLink><br />World J Psychiatry. 2022 May 19;12(5):708-721. (PMID: <searchLink fieldCode="PM" term="%2235663299%22">35663299)</searchLink><br />Epilepsia. 2015 Mar;56(3):382-92. (PMID: <searchLink fieldCode="PM" term="%2225631544%22">25631544)</searchLink><br />PLoS One. 2011;6(5):e20035. (PMID: <searchLink fieldCode="PM" term="%2221637831%22">21637831)</searchLink><br />J Neurol Sci. 2022 Mar 15;434:120095. (PMID: <searchLink fieldCode="PM" term="%2234979372%22">34979372)</searchLink><br />Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:51-7. (PMID: <searchLink fieldCode="PM" term="%2223352887%22">23352887)</searchLink><br />J ECT. 2016 Mar;32(1):49-54. (PMID: <searchLink fieldCode="PM" term="%2226252558%22">26252558)</searchLink><br />Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110178. (PMID: <searchLink fieldCode="PM" term="%2233197507%22">33197507)</searchLink><br />PLoS One. 2012;7(6):e39516. (PMID: <searchLink fieldCode="PM" term="%2222724025%22">22724025)</searchLink><br />Psychiatry Res. 2023 Jun;324:115192. (PMID: <searchLink fieldCode="PM" term="%2237054552%22">37054552)</searchLink><br />J Psychiatr Res. 2016 Nov;82:30-9. (PMID: <searchLink fieldCode="PM" term="%2227459030%22">27459030)</searchLink><br />Am J Psychiatry. 2006 Nov;163(11):1905-17. (PMID: <searchLink fieldCode="PM" term="%2217074942%22">17074942)</searchLink><br />Eur Neuropsychopharmacol. 2019 Aug;29(8):925-935. (PMID: <searchLink fieldCode="PM" term="%2231279591%22">31279591)</searchLink><br />Mol Psychiatry. 2015 May;20(5):609-14. (PMID: <searchLink fieldCode="PM" term="%2225092248%22">25092248)</searchLink><br />J Pain. 2010 Mar;11(3):287-90. (PMID: <searchLink fieldCode="PM" term="%2219944649%22">19944649)</searchLink><br />CNS Neurosci Ther. 2024 Mar;30(3):e14690. (PMID: <searchLink fieldCode="PM" term="%2238529527%22">38529527)</searchLink><br />Int J Psychophysiol. 2009 Apr;72(1):46-50. (PMID: <searchLink fieldCode="PM" term="%2218824045%22">18824045)</searchLink><br />J Neurosci. 2009 Jul 1;29(26):8586-94. (PMID: <searchLink fieldCode="PM" term="%2219571149%22">19571149)</searchLink><br />Cereb Cortex. 2009 Oct;19(10):2485-97. (PMID: <searchLink fieldCode="PM" term="%2219592571%22">19592571)</searchLink> – Name: GrantInfo Label: Grant Information Group: Grant Data: 82171508 National Natural Science Foundation of China; 2025JJ60706 Natural Science Foundation of Hunan Province – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>cerebellum; functional connectivity; neuroimaging–transcription association analysis; the default‐mode network; treatment‐resistant depression – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260508 <i>Date Completed: </i>20260806 <i>Latest Revision: </i>20260813 – Name: DateUpdate Label: Update Code Group: Date Data: 20260813 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13447124 – Name: DOI Label: DOI Group: ID Data: 10.1111/pcn.70071 – Name: AN Label: PMID Group: ID Data: 42099010 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42099010 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/pcn.70071 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 655 Subjects: – SubjectFull: Humans Type: general – SubjectFull: Female Type: general – SubjectFull: Male Type: general – SubjectFull: Adult Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Magnetic Resonance Imaging Type: general – SubjectFull: Depressive Disorder, Treatment-Resistant therapy Type: general – SubjectFull: Depressive Disorder, Treatment-Resistant diagnostic imaging Type: general – SubjectFull: Depressive Disorder, Treatment-Resistant physiopathology Type: general – SubjectFull: Depressive Disorder, Treatment-Resistant genetics Type: general – SubjectFull: Cerebellum diagnostic imaging Type: general – SubjectFull: Cerebellum physiopathology Type: general – SubjectFull: Nerve Net physiopathology Type: general – SubjectFull: Nerve Net diagnostic imaging Type: general – SubjectFull: Cerebral Cortex diagnostic imaging Type: general – SubjectFull: Cerebral Cortex physiopathology Type: general – SubjectFull: Default Mode Network diagnostic imaging Type: general – SubjectFull: Default Mode Network physiopathology Type: general – SubjectFull: Electroconvulsive Therapy Type: general – SubjectFull: Connectome Type: general – SubjectFull: Transcriptome Type: general Titles: – TitleFull: Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Han Y – PersonEntity: Name: NameFull: Lv D – PersonEntity: Name: NameFull: Yao P – PersonEntity: Name: NameFull: Chen L – PersonEntity: Name: NameFull: Yuan Y – PersonEntity: Name: NameFull: Zhao J – PersonEntity: Name: NameFull: Guo W – PersonEntity: Name: NameFull: Guo Z – PersonEntity: Name: NameFull: Ou Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1440-1819 Numbering: – Type: volume Value: 80 – Type: issue Value: 8 Titles: – TitleFull: Psychiatry and clinical neurosciences Type: main |
| ResultId | 1 |